Lenvenib 4mg Capsule is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient is Lenvatinib, a tyrosine kinase inhibitor. Lenvatinib works by blocking the activity of specific enzymes that are involved in tumor growth and the formation of new blood vessels that supply tumors. This dual action helps to slow down or stop the progression of cancer.
Lenvenib is primarily indicated for the treatment of differentiated thyroid cancer that is refractory to radioactive iodine treatment, as well as advanced renal cell carcinoma (kidney cancer) in combination with other therapies. It is also used for the treatment of unresectable hepatocellular carcinoma (liver cancer).
The dosage and administration of Lenvenib 4mg Capsule should be strictly as prescribed by a qualified healthcare professional. It is typically taken orally once daily. Common side effects may include fatigue, diarrhea, decreased appetite, weight loss, hypertension, and proteinuria. Serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately.
Lenvenib 4mg Capsule should be stored at room temperature, away from moisture and heat. Keep out of reach of children.
